158 related articles for article (PubMed ID: 21227895)
21. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
Piskin G; Heydendael VM; de Rie MA; Bos JD; Teunissen MB
Arch Dermatol Res; 2003 Mar; 294(12):559-62. PubMed ID: 12624782
[No Abstract] [Full Text] [Related]
22. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
23. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
24. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of Notch-1 in psoriasis: an immunohistochemical study.
Abdou AG; Maraee AH; Sharaf A; Elnaidany NF
Ann Diagn Pathol; 2012 Jun; 16(3):177-84. PubMed ID: 22197545
[TBL] [Abstract][Full Text] [Related]
26. Changes of skin blood flow and color on lesional and control sites during PUVA therapy for psoriasis.
Suh DH; Kwon TE; Kim SD; Park SB; Kwon OS; Eun HC; Youn JI
J Am Acad Dermatol; 2001 Jun; 44(6):987-94. PubMed ID: 11369911
[TBL] [Abstract][Full Text] [Related]
27. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
28. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy.
Fransson J; Ros AM
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):326-32. PubMed ID: 16313245
[TBL] [Abstract][Full Text] [Related]
30. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
31. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
32. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
33. Perforin expression is upregulated in the epidermis of psoriatic lesions.
Kastelan M; Prpić Massari L; Gruber F; Zamolo G; Zauhar G; Coklo M; Rukavina D
Br J Dermatol; 2004 Oct; 151(4):831-6. PubMed ID: 15491424
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-23: a key cytokine in inflammatory diseases.
Duvallet E; Semerano L; Assier E; Falgarone G; Boissier MC
Ann Med; 2011 Nov; 43(7):503-11. PubMed ID: 21585245
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis.
El-Domyati M; Moftah NH; Nasif GA; Abdel-Wahab HM; Barakat MT; Abdel-Aziz RT
Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):18-26. PubMed ID: 23281693
[TBL] [Abstract][Full Text] [Related]
36. Characterization of lesional psoriatic skin T lymphocyte clones.
Barna M; Snijdewint FG; van der Heijden FL; Bos JD; Kapsenberg ML
Acta Derm Venereol Suppl (Stockh); 1994; 186():9-11. PubMed ID: 8073850
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T
J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948
[TBL] [Abstract][Full Text] [Related]
38. Influence of PUVA and UVB radiation on expression of ICAM-1 and VCAM-1 molecules in psoriasis vulgaris.
Cabrijan L; Lipozencić J; Batinac T; Lenković M; Stanić Zgombić Z
Coll Antropol; 2008 Oct; 32 Suppl 2():53-6. PubMed ID: 19138007
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.
Ghoreschi K; Thomas P; Breit S; Dugas M; Mailhammer R; van Eden W; van der Zee R; Biedermann T; Prinz J; Mack M; Mrowietz U; Christophers E; Schlöndorff D; Plewig G; Sander CA; Röcken M
Nat Med; 2003 Jan; 9(1):40-6. PubMed ID: 12461524
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
Trott J; Gerber W; Hammes S; Ockenfels HM
Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
